BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 10382005)

  • 1. Progress toward eliminating Haemophilus influenzae type b disease among infants and children--United States, 1987-1997.
    Talan DA; Moran GJ; Pinner RW
    Ann Emerg Med; 1999 Jul; 34(1):109-11. PubMed ID: 10382005
    [No Abstract]   [Full Text] [Related]  

  • 2. From the Centers for Disease Control and Prevention. Progress toward eliminating Haemophilus influenzae type b disease among infants and children--United States, 1987-1997.
    JAMA; 1999 Feb; 281(5):409-10. PubMed ID: 9952189
    [No Abstract]   [Full Text] [Related]  

  • 3. From the Centers for Disease Control and Prevention. Progress toward elimination of Haemophilus influenzae type b invasive disease among infants and children-- United States, 1998-2000.
    JAMA; 2002 May; 287(17):2206-7. PubMed ID: 11987296
    [No Abstract]   [Full Text] [Related]  

  • 4. Progress toward elimination of Haemophilus influenzae type b invasive disease among infants and children--United States, 1998-2000.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2002 Mar; 51(11):234-7. PubMed ID: 11925021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progress toward eliminating Haemophilus influenzae type b disease among infants and children--United States, 1987-1997.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1998 Nov; 47(46):993-8. PubMed ID: 9843325
    [TBL] [Abstract][Full Text] [Related]  

  • 6. From the Centers for Disease Control and Prevention. Progress toward elimination of Haemophilus influenzae type b disease among infants and children--United States, 1987-1995.
    JAMA; 1996 Nov; 276(19):1542, 1544. PubMed ID: 8918839
    [No Abstract]   [Full Text] [Related]  

  • 7. From the Centers for Disease Control and Prevention. Progress toward elimination of Haemophilus influenzae type b disease among infants and children--United States, 1993-1994.
    JAMA; 1995 Nov; 274(17):1334-5. PubMed ID: 7563546
    [No Abstract]   [Full Text] [Related]  

  • 8. Progress in Haemophilus type b polysaccharide vaccine use in the United States.
    Cochi SL; O'Mara D; Preblud SR
    Pediatrics; 1988 Jan; 81(1):166-8. PubMed ID: 3257297
    [No Abstract]   [Full Text] [Related]  

  • 9. Impact of conjugate Haemophilus influenzae type b (Hib) vaccine introduction in South Africa.
    von Gottberg A; de Gouveia L; Madhi SA; du Plessis M; Quan V; Soma K; Huebner R; Flannery B; Schuchat A; Klugman K
    Bull World Health Organ; 2006 Oct; 84(10):811-8. PubMed ID: 17128361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. From the Centers for Disease Control and Prevention. Progress toward elimination of Haemophilus influenzae type b disease among infants and children--United States, 1987-1993.
    JAMA; 1994 Apr; 271(16):1231-2. PubMed ID: 8151887
    [No Abstract]   [Full Text] [Related]  

  • 11. Haemophilus influenzae vaccines: 1997.
    Murphy TV
    Adv Pediatr Infect Dis; 1997; 13():279-304. PubMed ID: 9544316
    [No Abstract]   [Full Text] [Related]  

  • 12. Increase in genetic diversity of Haemophilus influenzae serotype b (Hib) strains after introduction of Hib vaccination in The Netherlands.
    Schouls LM; van der Ende A; van de Pol I; Schot C; Spanjaard L; Vauterin P; Wilderbeek D; Witteveen S
    J Clin Microbiol; 2005 Jun; 43(6):2741-9. PubMed ID: 15956392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progress toward elimination of Haemophilus influenzae type b disease among infants and children--United States, 1987-1995.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1996 Oct; 45(42):901-6. PubMed ID: 8927012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serotyping discrepancies in Haemophilus influenzae type b disease--United States, 1998-1999.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2002 Aug; 51(32):706-7. PubMed ID: 12206286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progress toward elimination of Haemophilus influenzae type b disease among infants and children--United States, 1993-1994.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1995 Jul; 44(29):545-50. PubMed ID: 7616949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Continued shortage of Haemophilus influenzae Type b (Hib) conjugate vaccines and potential implications for Hib surveillance--United States, 2008.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2008 Nov; 57(46):1252-5. PubMed ID: 19023262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Update: prevention of Haemophilus influenzae type b disease.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1986 Mar; 35(11):170-4, 179-80. PubMed ID: 3081787
    [No Abstract]   [Full Text] [Related]  

  • 18. Haemophilus influenzae infections following licensure of the Hib vaccine.
    Alexander WJ; Shaw JF; Holmes JR
    N Engl J Med; 1987 Jul; 317(3):167-8. PubMed ID: 3496536
    [No Abstract]   [Full Text] [Related]  

  • 19. Leads from the MMWR. Update: prevention of Haemophilus influenzae type b disease.
    JAMA; 1986 Apr; 255(15):1990-2. PubMed ID: 3485727
    [No Abstract]   [Full Text] [Related]  

  • 20. Haemophilus influenzae type b vaccines: lessons for the future.
    Ward JI; Broome CV; Harrison LH; Shinefield H; Black S
    Pediatrics; 1988 Jun; 81(6):886-93. PubMed ID: 3259307
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.